GoodRx Holdings (GDRX) Gains from Investment Securities (2020 - 2022)

GoodRx Holdings (GDRX) posted Gains from Investment Securities of $1.2 million for Q4 2022, down 33.33% sequentially from $1.8 million in Q3 2022.

GoodRx Holdings (GDRX) Gains from Investment Securities (2020 - 2022) Analysis & Trends

GoodRx Holdings has reported Gains from Investment Securities for 2 years, with the latest figure at $1.2 million in Q4 2022.

Quarterly Gains from Investment Securities changed N/A year-over-year to $1.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $3.0 million (down 28.01% YoY) and the FY2022 annual result came in at $18.1 million, changed N/A from the prior year.
Gains from Investment Securities eased to $1.2 million in Q4 2022 per GDRX's latest filing, from $1.8 million in the prior quarter.
Over five years, Gains from Investment Securities peaked at $1.8 million in Q3 2022 and troughed at $1.2 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	GoodRx Holdings	1.27 Bn	972.56 Mn	179.41 Mn

Download Data